Thomas J. Maas concentrates his practice on resolving intellectual property disputes and has broad litigation experience in patent, antitrust, trademark, securities fraud and complex commercial cases. He has developed particular experience in the pharmaceutical industry, including patent/Hatch-Waxman, antitrust and contract litigation. Through this experience and his work with leading experts in the field, Thomas is highly knowledgeable on the intricacies of Food and Drug Administration (FDA) approval, exclusivity periods under Hatch-Waxman and the antitrust implications of settlements in pharmaceutical patent litigation.
Thomas also counsels clients with respect to trademark strategy and disputes, with a focus on the alcoholic beverage industry. His strong experience in this field has led to creative resolutions of multiple trademark disputes both before and during litigation.
Thomas has a strong commitment to obtaining cost effective, high quality outcomes for his clients. For example, he has created and implemented custom de-duplication software solutions to reduce review and production costs on large scale document reviews, leading to hundreds of thousands of dollars in savings for clients. In cases across multiple industries and practice areas, Thomas’s development of strong legal positions for his clients has led to favorable settlements, obviating the need for expensive trial and appellate processes. He has also co-authored multiple successful appellate briefs before various federal appellate courts.